Cargando…

Efficacy of Pitolisant 20 mg in Reducing Excessive Daytime Sleepiness and Fatigue in Patients with Obstructive Sleep Apnoea Syndrome: An Individual Patient Data Meta-analysis

BACKGROUND AND OBJECTIVE: Excessive daytime sleepiness (EDS) and fatigue are major complaints in patients with obstructive sleep apnoea (OSA) syndrome. Pitolisant is an orally active selective histamine H3 receptor (H3R) antagonist/inverse agonist, which enhances histaminergic transmissions in the b...

Descripción completa

Detalles Bibliográficos
Autor principal:	Lehert, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755655/ https://www.ncbi.nlm.nih.gov/pubmed/34859394 http://dx.doi.org/10.1007/s40261-021-01104-8

Ejemplares similares

Cortical thinning in male obstructive sleep apnoea patients with excessive daytime sleepiness
por: Li, Yezhou, et al.
Publicado: (2023)

Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility
por: Guevarra, Jay T, et al.
Publicado: (2020)

Effects of solriamfetol on on‐the‐road driving performance in participants with excessive daytime sleepiness associated with obstructive sleep apnoea
por: Vinckenbosch, Frederick, et al.
Publicado: (2022)

Treat the Symptom, Not the Cause? Pitolisant for Sleepiness in Obstructive Sleep Apnea
por: Trotti, Lynn Marie
Publicado: (2020)

Examining the impact of excessive daytime sleepiness on utility scores in patients with obstructive sleep apnoea and/or narcolepsy in five European countries
por: Cambron-Mellott, M. Janelle, et al.
Publicado: (2022)

Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials
por: Meskill, Gerard J., et al.
Publicado: (2021)

Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial
por: Dauvilliers, Yves, et al.
Publicado: (2020)

Time to Onset of Response to Pitolisant for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients With Narcolepsy: An Analysis of Randomized, Placebo-Controlled Trials
por: Watson, Nathaniel F., et al.
Publicado: (2021)

A novel parameter is better than the AHI to assess nocturnal hypoxaemia and excessive daytime sleepiness in obstructive sleep apnoea
por: Ma, Changxiu, et al.
Publicado: (2021)

Erratum: Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial
Publicado: (2020)

Genetic influences on the onset of obstructive sleep apnoea and daytime sleepiness: a twin study
por: Szily, Marcell, et al.
Publicado: (2019)

Risk of obstructive sleep apnea and excessive daytime sleepiness in hospitalized psychiatric patients
por: Talih, Farid R, et al.
Publicado: (2017)

Sex Differences in Excessive Daytime Sleepiness Among Patients With Obstructive Sleep Apnea
por: Lee, Sang-Ahm, et al.
Publicado: (2022)

Cancer-related fatigue presenting with excessive daytime sleepiness
por: Balachandran, Diwakar D, et al.
Publicado: (2017)

Excessive Daytime Sleepiness in Obstructive Sleep Apnea. Mechanisms and Clinical Management
por: Lal, Chitra, et al.
Publicado: (2021)

Post-COVID syndrome: Objective sleep-wake changes in patients with fatigue and excessive daytime sleepiness
por: Fregolente, L.G., et al.
Publicado: (2022)

Daytime sleepiness predicts inflammation and ambulatory blood pressure in sleep apnoea
por: Pak, Victoria M., et al.
Publicado: (2020)

Excessive Daytime Sleepiness as a Risk Factor for Obstructive Sleep Apnoea among Public Transport Drivers: A Cross-Sectional Study
por: Asha, C L, et al.
Publicado: (2023)

Inverse relationship of subjective daytime sleepiness to mortality in heart failure patients with sleep apnoea
por: Kasai, Takatoshi, et al.
Publicado: (2020)

Gender differences in the sleep variables contributing to excessive daytime sleepiness among patients with obstructive sleep apnea
por: Honig, Eliya, et al.
Publicado: (2021)

A mandibular advancement device did not affect daytime sleepiness and quality of life in obstructive sleep apnoea
por: Doff, Michiel H J
Publicado: (2015)

Altered irisin/BDNF axis parallels excessive daytime sleepiness in obstructive sleep apnea patients
por: More, Csaba E., et al.
Publicado: (2019)

Excessive daytime sleepiness among depressed patients
por: Mume, Celestine Okorome
Publicado: (2010)

Association between excessive daytime sleepiness, REM phenotype and severity of obstructive sleep apnea
por: Gabryelska, Agata, et al.
Publicado: (2020)

O029 Sleep architecture differs for individuals manifesting excessive daytime sleepiness with and without obstructive sleep apnea
por: Chen, X, et al.
Publicado: (2022)

Use of CPAP to reduce arterial stiffness in moderate-to-severe obstructive sleep apnoea, without excessive daytime sleepiness (STIFFSLEEP): an observational cohort study protocol
por: Mineiro, Maria Alexandra, et al.
Publicado: (2016)

Daytime Sleepiness and Quality of Life in Obstructive Sleep Apnoea Patients before and after Long-Term Mandibular Advancement Device Treatment
por: Halfeld, Signe, et al.
Publicado: (2022)

Excessive Daytime Sleepiness in Parkinson’s Disease
por: Liu, Hanshu, et al.
Publicado: (2022)

Use of the pictorial Sleepiness and Sleep Apnoea Scale in Chinese patients with suspected obstructive sleep apnoea syndrome
por: Ji, Yang, et al.
Publicado: (2021)

Factors contributing to sleep disturbances and excessive daytime sleepiness in patients with Parkinson's disease
por: Ogaki, Keitaro, et al.
Publicado: (2023)

Obstructive Sleep Apnea With or Without Excessive Daytime Sleepiness: Clinical and Experimental Data-Driven Phenotyping
por: Garbarino, Sergio, et al.
Publicado: (2018)

Excessive Daytime Sleepiness in Depression and Obstructive Sleep Apnea: More Than Just an Overlapping Symptom
por: Zhang, Danwei, et al.
Publicado: (2021)

Non-sleepy obstructive sleep apnoea: to treat or not to treat?
por: Altintas, Nejat, et al.
Publicado: (2019)

Self-reported sleepiness and not the apnoea hypopnoea index is the best predictor of sleepiness-related accidents in obstructive sleep apnoea
por: Philip, P., et al.
Publicado: (2020)

The Association between the Phenotype of Excessive Daytime Sleepiness and Blood Pressure in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome
por: Wang, Qimin, et al.
Publicado: (2014)

Current Management of Residual Excessive Daytime Sleepiness Due to Obstructive Sleep Apnea: Insights for Optimizing Patient Outcomes
por: Mehra, Reena, et al.
Publicado: (2021)

Interaction between apolipoprotein E genotypes, excessive daytime sleepiness, and cognitive function in obstructive sleep apnea patients
por: Balthazar, Fernanda Maurer, et al.
Publicado: (2022)

Comparison of modafinil and pitolisant in narcolepsy: a non-inferiority meta-analytical approach
por: Lehert, Philippe, et al.
Publicado: (2020)

Excessive daytime sleepiness in adolescents: current treatment strategies
por: Hein, Matthieu, et al.
Publicado: (2020)

Risk of obstructive sleep apnea, excessive daytime sleepiness and depressive symptoms in a Nigerian elderly population
por: Fawale, Michael B., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a0vfn00km1d6i9lmern497arrj